Development and Validation of the Quality-of-Life Assessment System for Lung Cancer Based on Traditional Chinese Medicine

Por Wan, Chonghua, You, Shengfu, Quan, Peng, Song, Yi, Liu, Tao, Lu, Jingen, Zheng, Peiyong
Publicado em 2012

Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq

Por Zhu, Mingzhe, Hao, Shijun, Liu, Tao, Yang, Lili, Zheng, Peiyong, Zhang, Li, Ji, Guang
Publicado no Oncotarget (2017)

Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion

Por Yang, Lili, Lin, Weili, Nugent, Colleen A., Hao, Shijun, Song, Haiyan, Liu, Tao, Zheng, Peiyong
Publicado no Int J Genomics (2017)

Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway

Por Li, Zhongping, Xu, Jiaoya, Zheng, Peiyong, Xing, Lianjun, Shen, Hongyi, Yang, Lili, Zhang, Li, Ji, Guang
Publicado no Int J Clin Exp Med (2015)

Elevated serum A20 is associated with severity of chronic hepatitis B and A20 inhibits NF-κB-mediated inflammatory response

Por Xu, Hanchen, Wang, Lei, Zheng, Peiyong, Liu, Yang, Zhang, Chunlei, Jiang, Kaiping, Song, Haiyan, Ji, Guang
Publicado no Oncotarget (2017)

Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD

Por Zhu, Mingzhe, Wang, Qianlei, Zhou, Wenjun, Liu, Tao, Yang, Lili, Zheng, Peiyong, Zhang, Li, Ji, Guang
Publicado no Sci Rep (2018)

Inhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule

Por Wang, Miao, Sun, Shanshan, Wu, Tao, Zhang, Li, Song, Haiyan, Hao, Weiwei, Zheng, Peiyong, Xing, Lianjun, Ji, Guang
Publicado em 2013